Terray Therapeutics Receives Investment From NVIDIA
By Annie Baker ● Nov 20, 2023
Terray Therapeutics - a biotechnology company integrating scale experimentation and generative AI to improve the speed, cost, and success rate of small molecule drug discovery and development - recently announced an equity investment by NVentures, NVIDIA’s venture capital arm. Additional financing included a strong syndicate of new and existing institutional investors, including industry leaders John Maraganore, founding Chief Executive Officer of Alnylam Pharmaceuticals, and Bassil Dahiyat, founder and Chief Executive Officer of Xencor.